N-arylpiperazinyl derivatives of 2,3-dihydrobenzoxazin[1,4]-3-ones synthesis and normolipemic activity.
Four series of N-arylpiperazinyl derivatives of the 7-substituted 2,3-dihydrobenzoxazin[1,4]-3-one were synthesized and preliminarily tested for hypolipemic activity. Substitutions in position 2 were performed. Hypotriglyceridemic activity was shown to be present in a number of compounds.